Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 40,000 shares at $63.90 ($2.6M) on 2020-02-18, disclosed to the SEC on 2020-02-19.
Open-market sale of $2.6M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.90 | 4,386 | $280K | 11.0% |
| 2 | $63.90 | 4,386 | $280K | 11.0% |
| 3 | $63.90 | 15,614 | $998K | 39.0% |
| 4 | $63.90 | 15,614 | $998K | 39.0% |
| Total | $63.90 avg | 40,000 | $2.6M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |